TDOC
Income statement / Annual
Last year (2024), Teladoc Health, Inc.'s total revenue was $2.57 B,
a decrease of 1.26% from the previous year.
In 2024, Teladoc Health, Inc.'s net income was -$1.00 B.
See Teladoc Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.57 B |
$2.60 B |
$2.41 B |
$2.03 B |
$1.09 B |
$553.31 M |
$417.91 M |
$233.28 M |
$123.16 M |
$77.38 M |
| Cost of Revenue |
$751.27 M
|
$760.03 M
|
$743.99 M
|
$650.26 M
|
$390.83 M
|
$184.47 M
|
$128.74 M
|
$61.62 M
|
$31.97 M
|
$21.04 M
|
| Gross Profit |
$1.82 B
|
$1.84 B
|
$1.66 B
|
$1.38 B
|
$703.13 M
|
$368.84 M
|
$289.17 M
|
$171.66 M
|
$91.19 M
|
$56.34 M
|
| Gross Profit Ratio |
0.71
|
0.71
|
0.69
|
0.68
|
0.64
|
0.67
|
0.69
|
0.74
|
0.74
|
0.73
|
| Research and Development Expenses |
$307.27 M
|
$348.52 M
|
$333.63 M
|
$311.88 M
|
$164.94 M
|
$64.64 M
|
$54.37 M
|
$34.46 M
|
$21.82 M
|
$14.21 M
|
| General & Administrative Expenses |
$435.49 M
|
$464.66 M
|
$449.86 M
|
$438.01 M
|
$506.68 M
|
$164.46 M
|
$118.78 M
|
$81.27 M
|
$52.69 M
|
$54.84 M
|
| Selling & Marketing Expenses |
$705.79 M
|
$902.63 M
|
$850.71 M
|
$667.31 M
|
$380.20 M
|
$174.61 M
|
$144.26 M
|
$95.65 M
|
$60.96 M
|
$38.21 M
|
| Selling, General & Administrative Expenses |
$1.14 B
|
$1.37 B
|
$1.30 B
|
$1.11 B
|
$886.88 M
|
$339.07 M
|
$263.05 M
|
$176.91 M
|
$113.65 M
|
$93.06 M
|
| Other Expenses |
$1.39 B
|
$375.12 M
|
$256.03 M
|
$204.24 M
|
$69.50 M
|
$38.95 M
|
$37.72 M
|
$22.48 M
|
$11.43 M
|
$4.86 M
|
| Operating Expenses |
$2.84 B
|
$2.09 B
|
$1.89 B
|
$1.62 B
|
$1.12 B
|
$442.66 M
|
$355.14 M
|
$233.85 M
|
$146.89 M
|
$112.13 M
|
| Cost And Expenses |
$3.59 B
|
$2.85 B
|
$2.63 B
|
$2.27 B
|
$1.51 B
|
$627.13 M
|
$483.87 M
|
$295.48 M
|
$178.86 M
|
$133.17 M
|
| Interest Income |
$57.07 M
|
$46.78 M
|
$9.27 M
|
$80.37 M
|
$59.95 M
|
$29.36 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$23.80 M
|
$22.28 M
|
$9.27 M
|
$80.37 M
|
$60.50 M
|
$29.01 M
|
$26.11 M
|
$17.49 M
|
$2.59 M
|
$2.20 M
|
| Depreciation & Amortization |
$382.84 M
|
$351.32 M
|
$270.64 M
|
$219.62 M
|
$78.09 M
|
$38.95 M
|
$35.60 M
|
$19.10 M
|
$8.27 M
|
$4.86 M
|
| EBITDA |
-$587.01 M |
$154.00 M |
-$13.38 B |
-$84.67 M |
-$438.01 M |
-$41.49 M |
-$35.25 M |
-$70.42 M |
-$62.85 M |
-$50.92 M |
| EBITDA Ratio |
-0.23
|
0.06
|
5.6
|
-0.01
|
-0.31
|
-0.05
|
-0.07
|
-0.18
|
-0.39
|
-0.66
|
| Operating Income Ratio |
-0.4
|
-0.1
|
5.48
|
-0.12
|
-0.38
|
-0.13
|
-0.17
|
-0.32
|
-0.51
|
-0.72
|
| Total Other Income/Expenses Net |
$27.23 M
|
$28.95 M
|
-$10.13 M
|
-$119.03 M
|
-$69.57 M
|
-$29.01 M
|
-$26.11 M
|
-$31.61 M
|
-$11.04 M
|
-$2.20 M
|
| Income Before Tax |
-$993.65 M
|
-$219.61 M
|
-$13.66 B
|
-$384.66 M
|
-$575.99 M
|
-$109.46 M
|
-$96.97 M
|
-$107.01 M
|
-$73.71 M
|
-$57.98 M
|
| Income Before Tax Ratio |
-0.39
|
-0.08
|
-5.68
|
-0.19
|
-0.53
|
-0.2
|
-0.23
|
-0.46
|
-0.6
|
-0.75
|
| Income Tax Expense |
$7.59 M
|
$760,000.00
|
-$3.81 M
|
$44.14 M
|
-$90.86 M
|
-$10.59 M
|
$118,000.00
|
-$225,000.00
|
$510,000.00
|
$36,000.00
|
| Net Income |
-$1.00 B
|
-$220.37 M
|
-$13.66 B
|
-$428.79 M
|
-$485.14 M
|
-$98.86 M
|
-$97.08 M
|
-$106.78 M
|
-$74.22 M
|
-$58.02 M
|
| Net Income Ratio |
-0.39
|
-0.08
|
-5.68
|
-0.21
|
-0.44
|
-0.18
|
-0.23
|
-0.46
|
-0.6
|
-0.75
|
| EPS |
-5.87 |
-1.36 |
-84.6 |
-2.73 |
-5.36 |
-1.38 |
-1.47 |
-1.93 |
-1.75 |
-2.91 |
| EPS Diluted |
-5.87 |
-1.34 |
-84.6 |
-2.73 |
-5.36 |
-1.38 |
-1.47 |
-1.93 |
-1.75 |
-2.91 |
| Weighted Average Shares Out |
$170.56 M
|
$162.17 M
|
$161.46 M
|
$156.94 M
|
$90.51 M
|
$71.84 M
|
$65.84 M
|
$55.43 M
|
$42.33 M
|
$19.92 M
|
| Weighted Average Shares Out Diluted |
$170.56 M
|
$164.58 M
|
$161.46 M
|
$156.94 M
|
$90.51 M
|
$71.84 M
|
$65.84 M
|
$55.43 M
|
$42.33 M
|
$19.92 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
